[1]
R., P. and T. N., K. 2020. Evaluation of efficacy and safety profile of tamsulosin in benign prostatic hyperplasia. International Journal of Basic & Clinical Pharmacology. 9, 2 (Jan. 2020), 332–335. DOI:https://doi.org/10.18203/2319-2003.ijbcp20200186.